List view / Grid view
Big data covers every facet of our working life. Every aspect of pharmaceutical research and development involves the generation of huge quantities of data, with the expectation that we can turn this information rapidly into useful knowledge, which in turn can be used to make ‘data-driven’ decisions to better understand…
MedUni Vienna researchers have developed a way to use retinal imaging to diagnose diabetes, explaining how the technique could be used for other conditions...
Most pharmaceutical companies are now outsourcing work to smaller firms, and here, European Pharmaceutical Review looks at current trends...
PharmaIntegrity makes it quick and easy to identify and trend cleanroom contamination problems before they occur...
Improving data integrity is the aim of a new guide published by the Russian State Institute for Drugs and Good Practices in collaboration with consultancy PQE Group...
Maintaining public confidence in the use of Big Data for health research is essential, according to international researchers.
The pharmacovigilance of new drugs and drug formulations undertaken in New Zealand should be proactive, says a leading expert.
More guidance is needed on the appropriate control of non-mutagenic impurities during clinical development, explains Dave P Elder, JPAG Member and pharmaceutical industry consultant, in this audio interview.
Taking advantage of technology developed in recent years, MECO announces smartANALYTICS® as a means of connecting its water purification machines and systems with big data analytics and in house expertise...
A group of researchers is showing how artificial intelligence approaches can help identify cause-effect relationships within data...
In this issue; recent developments in turning promising compounds into drug candidates, reviewing the latest trends in pharmaceutical microbiology and their implications, and a roundtable debate featuring the views of five industry leaders.
Global regulatory authorities continue to push Quality-by-Design (QbD) on pharmaceutical groups and their supporting corporate informatics infrastructure...
An international team of researchers has developed a computational resource that provides a 3D view of genes, proteins and metabolites involved in human metabolism...
Bottmingen, The latest version of eve® can integrate with a wide range of third-party bioreactors and equipment from a number of different suppliers, e.g. Sartorius DCU, Applikon or Matlab...
Health Data Research UK is awarding £30 million funding to six sites across the UK to address challenging healthcare issues through the use of data science...
